Miguel Alejandro Galindo-Campos (Miguel A Galindo-Campos)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Dna Damage Response

Smoking Cessation

Endoplasmic Reticulum Stress

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Nura Lutfi, Miguel Alejandro Galindo-Campos, José Yélamos
Impact of DNA Damage Response-Targeted Therapies on the Immune Response to Tumours. Cancers 13 (23) (2021)
Miguel Alejandro Galindo-Campos, Nura Lutfi, Sarah Bonnin, Carlos Manuel Martínez, Talía Velasco-Hernandez, Violeta García-Hernández, Juan Martin-Caballero, Coral Ampurdanés, Ramón Gimeno, Lluis Colomo, Gael Roue, Guillaume Guilbaud, Françoise Dantzer, Pilar Navarro, Matilde Murga, Oscar Fernandez-Capetillo, Anna Bigas, Pablo Menendez, Julian Sale, José Yélamos
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice. Blood (2021)
Lucia Moreno-Lama, Miguel Alejandro Galindo-Campos, Carlos Manuel Martínez, Laura Comerma, Ivonne Vazquez, María Vernet-Tomas, Coral Ampurdanés, Nura Lutfi, Juan Martin-Caballero, Françoise Dantzer, Miguel Quintela-Fandino, Syed O Ali, Jaime Jimeno, José Yélamos
Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice. Oncogene 39 (13) (2020)
Max Hardy-Werbin, Raúl Del Rey-Vergara, Miguel Alejandro Galindo-Campos, Laura Moliner, Edurne Arriola
MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside. Cancers 11 (10) (2019)